Bazedoxifene

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Pancreatic AdenocarcinomaEstrogen

58 competitors in Pancreatic Adenocarcinoma

#DrugCompanyPhaseTrials

1

Gemzar

Johnson & Johnson

Phase 3

472

Xeloda

EEngelhard Arzneimittel GmbH & Co.KG

Approved

103

Abraxane

Bristol-Myers Squibb

Phase 3

264

Taxol

Teva

Approved

—5

Eloxatin

Teva

Phase 3

126

Mfolfirinox

Incyte

Phase 3

77

Opdivo

Bristol-Myers Squibb

Phase 2

78

Camptosar

Pfizer

Phase 2

59

Imfinzi

AstraZeneca

Phase 2

310

Yervoy

Bristol-Myers Squibb

Phase 2

3Show 41 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Postmenopausal Women3 trials

Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

Completed·Pfizer·Phase 1·NCT00706225·30 enrolled

Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women

Completed·IInstituto Palacios·Phase 4·NCT02090400·110 enrolled

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Terminated·Pfizer·Phase 1·NCT01634789·2 enrolled

Postmenopausal Osteoporosis2 trials

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Completed·Pfizer·Phase 3·NCT00808132·1,886 enrolled

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Completed·Pfizer·Phase 2·NCT00238745·375 enrolled

Trial1 trial

HDDO-1614 Intervention Trial

Completed·HHyundai Pharmaceutical Co., LTD.·Phase 1·NCT03234244·37 enrolled

Pancreatic Adenocarcinoma1 trial

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma

Unknown status·HHôpital Fribourgeois·N/A·NCT04812808·10 enrolled

Safety and Efficacy1 trial

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Completed·Pfizer·Phase 3·NCT00384072·500 enrolled

5 more indications

Observational Study1 trial

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

Terminated·Pfizer··NCT00847821·185 enrolled

Breast Cancer1 trial

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Completed·—·Phase 1/2·NCT02448771·36 enrolled

Estrogen1 trial

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Active, not recruiting·UUniversity of Kansas Medical Center·Phase 2·NCT04821141·120 enrolled

Glucocorticoid1 trial

Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients

Completed·HHanyang University·Phase 4·NCT02602704·114 enrolled

Unspecified3 trials

AK-R215 Pharmacokinetic Study Phase I

Unknown status·AAlvogen Korea·Phase 1·NCT03321318·52 enrolled

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Completed·Pfizer··NCT01416194·10,497 enrolled

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Completed·Pfizer··NCT01470326·3,187 enrolled

Details

Drug Info

Related News